Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Interventional Cardiology KOL Joins Abiomed

This article was originally published in Clinica

Executive Summary

Percutaneous heart pump maker Abiomed has appointed Dr Seth Bilazarian Vice-President of Interventional Cardiology Programs. Bilazarian has over 20 years’ experience practicing interventional cardiology in the cath lab with expertise in hemodynamic support; he has also served as physician advisor to the cardiac device panel of the US FDA. His role at Abiomed includes collaborating with other physicians to develop best practices for use of the company’s Impella platform in Protected PCI and helping the company develop new devices within the platform. Abiomed is currently seeking expanded indications for Impella to include patients suffering cardiogenic shock following acute myocardial infarction or cardiac surgery.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst